Richard A Colvin Bluebird Bio, Inc. (BLUE) insider trading activity

Richard A Colvin is Chief Medical Officer of bluebird bio, Inc.. Currently has a direct ownership of 168,368 shares of BLUE, which is worth approximately $79,132. The most recent transaction as insider was on Sep 30, 2024, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 168K

42.24% 3M change

33.91% 12M change

Total Value Held $79,132

Richard A Colvin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 30 2024	BUY Grant, award, or other acquisition	-	50,000 Added 22.9%	168,368 Common Stock
Mar 01 2024	SELL Open market or private sale	$10,358 $1.53 p/Share	6,770 Reduced 5.41%	118,368 Common Stock
Jan 05 2024	SELL Open market or private sale	$847 $1.42 p/Share	597 Reduced 0.47%	125,138 Common Stock
Nov 02 2023	SELL Open market or private sale	$6,982 $2.98 p/Share	2,343 Reduced 1.83%	125,735 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	55,000 Added 30.04%	128,078 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$7,356 $6.38 p/Share	1,153 Reduced 1.55%	73,078 Common Stock
Jan 11 2023	SELL Open market or private sale	$4,344 $7.8 p/Share	557 Reduced 0.74%	74,231 Common Stock
Nov 04 2022	SELL Open market or private sale	$1,397 $6.41 p/Share	218 Reduced 0.29%	74,788 Common Stock
Nov 01 2022	BUY Grant, award, or other acquisition	-	30,000 Added 28.57%	75,006 Common Stock

RAC

Richard A Colvin

Chief Medical Officer

Somerville, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Value

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

Operation

Value

Type

News

Receive news related to bluebird bio, Inc.

Track Activities on BLUE

Account